Skip to main content
Log in

17α-hydroxylase deficiency

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Eberlein W.R., Bongiovanni A.M. Plasma and urinary corticoids in the hypertensive form of congenital adrenal hyperplasia. J. Biol. Chem. 223: 85, 1956.

    CAS  PubMed  Google Scholar 

  2. Biglieri E.G., Herron MA, Brust N. 17-hydroxylation deficiency in man. J. Clin. Invest. 45: 1946, 1966.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Yanase T., Simpson E.R., Waterman M.R. 17α-hydroxylase/17,20 lyase deficiency: From clinical investigation to molecular definition. Endocrine Rev. 12: 91, 1991.

    Article  CAS  Google Scholar 

  4. Kater C.E., Biglieri E.G. Disorders of steroid 17α-hydroxylase deficiency. In: Bravo E. (Ed), Endocrinology and Metabolism Clinics of North America. WB Saunders Co., Philadelphia, 1994, vol. 23, p. 341.

    CAS  PubMed  Google Scholar 

  5. Moreira A.C., Leal A.M.O., Castro M. Characterization of adrenocortical secretion in a patient with 17α-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 71: 86, 1990.

    Article  CAS  PubMed  Google Scholar 

  6. Fraser R., Brown J.J., Mason P.A. Severe hypertension with absent secondary characteristics due to partial deficiency of steroid 17α-hydroxylase deficiency. J. Hum. Hypertension 1: 53, 1987.

    CAS  Google Scholar 

  7. Biglieri E.G. 17α-hydroxylase deficiency: implications on steroidogenesis. In: Biglieri E.G., Melby C.J. (Eds), Endocrine Hypertension. Raven Press Ltd, New York, 1990, p. 125–136.

    Google Scholar 

  8. Yamakita N., Murase H., Yasuka H. Possible hyperaldosteronism and discrepancy in enzyme activity deficiency in adrenal and gonadal glands in Japanese patients with 17α-hydroxylase deficiency. Endocrinol. 3: 515, 1989.

    Google Scholar 

  9. Kater C.E., Biglieri E.G., Brust N., et al. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17α-hydroxylase deficiency syndrome. J. Clin. Endocrinol. Metab. 55: 295, 1982.

    Article  CAS  PubMed  Google Scholar 

  10. Kater C.E., Biglieri E.G., Rost C.R. Constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosteroid methyloxidase type II activity in disorders with variable aldosterone production. J. Clin. Endocrinol. Metab. 60: 225, 1985.

    Article  CAS  PubMed  Google Scholar 

  11. Itatsu T., Naitoh K., Matsuda N., Matsui N. A case of 17α-hydroxylase deficiency with bone abnormalities (Japanese). J. Jap. Soc. Intern. Med. 69: 960, 1971.

    Article  Google Scholar 

  12. Mallin S.R. Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency syndrome associated with right adrenal tumor. Clin. Exper. Hyper. 6: 863, 1984.

    Google Scholar 

  13. D’Armiento M., Reda G., Kater C.E., et al. 17α-hydroxylase deficiency: mineralocorticoid hor

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biglieri, E.G. 17α-hydroxylase deficiency. J Endocrinol Invest 18, 540–544 (1995). https://doi.org/10.1007/BF03349765

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349765

Keywords

Navigation